Sinema and Manchin Know What They Are Doing
Newsweek|November 26, 2021
Business-friendly Democrats don’t need to worry about reelection when they can have lucrative second careers as lobbyists
ANDREW PEREZ and WALKER BRAGMAN
Sinema and Manchin Know What They Are Doing

IT’S A CORE PRINCIPLE of economics that people do what they are incentivized to do. That may be why Democratic Senators Kyrsten Sinema of Arizona and Joe Manchin of West Virginia haven’t hesitated to oppose popular progressive policies in their own party’s spending bill: They can bet on getting a payoff in the end.

During the fight over Democrats’ social spending reconciliation bill, Sinema, for example, has played a prominent—albeit silent—role in watering down the party’s plan to allow Medicare to negotiate prescription drug prices. She’s also helped gut Democrats’ plan to expand Medicare benefits, nixed tax hikes on the wealthy and corporations and pushed to make the overall bill smaller. While Sinema isn’t up for reelection until 2024, she is polling terribly and already facing the threat of a well-financed primary challenge.

While Manchin has a personal financial interest in protecting the fossil fuel industry, he’s also worked diligently to deny new Medicare dental benefits that seniors in his state desperately need. Manchin has been on a fundraising tear this year, despite stating recently that he hasn’t decided whether he’ll run for reelection in 2024.

To understand what’s in it for conservative Democratic senators who play the party’s villain role, look at those who came before them: Many of those who do big business’ bidding and then either fail to win reelection or retire quickly end up scoring lucrative careers on K Street. It’s the ultimate win-win situation.

Esta historia es de la edición November 26, 2021 de Newsweek.

Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.

Esta historia es de la edición November 26, 2021 de Newsweek.

Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.

MÁS HISTORIAS DE NEWSWEEKVer todo
Wendi McLendon-Covey
Newsweek US

Wendi McLendon-Covey

AFTER 10 YEARS OF PLAYING BEVERLY GOLDBERG ON THE GOLDBERGS, Wendi McLendon-Covey was not eager for a break. \"I need to go do a job where I can just throw everything at it and then come home totally exhausted.\"

time-read
1 min  |
November 22, 2024
'I'm the Highest Earner in Esports'
Newsweek US

'I'm the Highest Earner in Esports'

Johan \"NOtail\" Sundstein has won over $7 million but says, \"I don't really crave that status.... I play for my own reasons\"

time-read
6 minutos  |
November 22, 2024
AMERICA'S BEST Weight Loss CLINICS & CENTERS 2025
Newsweek US

AMERICA'S BEST Weight Loss CLINICS & CENTERS 2025

WHETHER IT'S FOR MEAL PLANS, PROFESSIONAL guidance or access to medications like GLP-1s, weight loss clinics can offer personalized assistance for those hoping to make sustainable lifestyle changes.

time-read
3 minutos  |
November 22, 2024
AMERICA'S MOST ANTICIPATED NEW VEHICAL 2025
Newsweek US

AMERICA'S MOST ANTICIPATED NEW VEHICAL 2025

WHETHER IT'S A NEWLY IMAGined sport utility vehicle or the re-emergence of a highly regarded halo car, the vehicles coming to market in 2025 prove that Americans' attitudes about personal transportation are diverse and are being served from all angles.

time-read
10+ minutos  |
November 22, 2024
'THIS IS WHAT DEMOCRACY LOOKS LIKE'
Newsweek US

'THIS IS WHAT DEMOCRACY LOOKS LIKE'

What Donald Trump's historic U.S. presidential election victory means to America - and the world

time-read
8 minutos  |
November 22, 2024
Trump Won, Mainstream Media Lost
Newsweek US

Trump Won, Mainstream Media Lost

A broken business model exacerbated by a collapse in influence has the Fourth Estate entering another Donald Trump term in trouble

time-read
10+ minutos  |
November 22, 2024
Can Alternative Therapies Treat Cancer?
Newsweek US

Can Alternative Therapies Treat Cancer?

Doctor and breast cancer survivor Liz O'Riordan addresses misinformation around managing the disease

time-read
5 minutos  |
November 15, 2024
Falling for Romance
Newsweek US

Falling for Romance

A new book, Nora Ephron at the Movies, celebrates the writer/director best known for her iconic rom-coms and strong female characters

time-read
5 minutos  |
November 15, 2024
Cracking the Norse Code
Newsweek US

Cracking the Norse Code

Walrus DNA has shown that Vikings were likely the first to have encountered Indigenous North Americans

time-read
4 minutos  |
November 15, 2024
Monumental Shift
Newsweek US

Monumental Shift

The discovery of 165-million-year-old crystals Easter Island has upended the longheld notion of how the Earth's \"conveyor belt\" moves

time-read
6 minutos  |
November 15, 2024